C5a receptor antagonists

Details for Australian Patent Application No. 2004259282 (hide)

Owner Jerini AG

Inventors Hummel, Gerd; Scharn, Dirk; Locardi, Elsa; Schnatbaum, Karsten; Polakowski, Thomas

Agent Pizzeys

Pub. Number AU-A-2004259282

PCT Pub. Number WO2005/010030

Priority 03016233.3 17.07.03 EP

Filing date 19 July 2004

Wipo publication date 3 February 2005

International Classifications

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/010030 Priority application(s): WO2005/010030

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259288-Crystalline 6-n-pyridylmethylaminoindolocarbazole compounds

2004259281-7a5/prognostin and use thereof for the diagnostic and therapy of tumors